The most straightforward cheaper alternative to Symbicort is its generic version, Breyna, which contains the same two active ingredients (budesonide and formoterol) at a lower price. Beyond the generic, several other combination inhalers treat the same conditions, and recent manufacturer price caps have changed the math on what you’ll actually pay out of pocket.
Breyna: The Generic Symbicort
The FDA approved Breyna in 2022, manufactured by Viatris (formerly Mylan Pharmaceuticals). It’s the first and currently only approved generic version of Symbicort, delivering the same medication in the same type of pressurized inhaler. Because it’s a true generic, your doctor doesn’t need to write a new prescription for a different drug. In many cases, pharmacies can substitute it automatically.
What you’ll pay varies widely depending on your insurance. Some patients report paying as little as $30 per month, while others without favorable coverage have seen prices closer to $89 or even $270 for the same inhaler. If your pharmacy quotes you a high price for Breyna, it’s worth calling other pharmacies or checking discount programs like GoodRx or RxSaver, which can produce very different numbers from one location to the next.
The $35 Monthly Cap on Brand-Name Inhalers
AstraZeneca, the maker of Symbicort, now caps out-of-pocket costs at $35 per inhaler per month for eligible patients. This cap went into effect in June 2024 as part of a broader commitment by three major inhaler manufacturers (AstraZeneca, Boehringer Ingelheim, and GSK) following a U.S. Senate investigation into inhaler pricing.
If you have commercial insurance, AstraZeneca’s savings card brings your copay down to as low as $35 for each 30-day supply. The card is available as a download from AstraZeneca’s patient support website. For people without insurance or those on Medicare who struggle to afford their medications, the AZ&Me program may provide Symbicort at no cost, though you’ll need to check eligibility through their site.
This means brand-name Symbicort at $35 per month could actually be cheaper than the generic, depending on your insurance plan. It’s worth comparing before assuming the generic saves you more.
Other Combination Inhalers
Symbicort combines an inhaled steroid with a long-acting bronchodilator. Several other inhalers use the same approach with different active ingredients. Your doctor might suggest switching to one of these if your insurance covers it at a lower tier or if you respond better to a different formulation.
Advair (fluticasone/salmeterol) is the most common alternative and has been available in generic form for several years, which generally makes it less expensive. It comes in two versions: a pressurized inhaler (Advair HFA) that works similarly to Symbicort, and a dry powder inhaler (Advair Diskus) that you activate by breathing in. Both are taken twice daily, just like Symbicort. Generic fluticasone/salmeterol inhalers are widely available and often among the cheapest options in this drug class.
Breo Ellipta (fluticasone furoate/vilanterol) is a once-daily dry powder inhaler made by GSK, which also committed to the $35 price cap. Taking one puff per day instead of two puffs twice daily is a meaningful convenience difference, and GSK’s price cap may make it affordable even as a brand-name product.
Pressurized Inhalers vs. Dry Powder Inhalers
One practical detail that matters when switching: not all inhalers work the same way physically. Symbicort and its generic Breyna are pressurized metered-dose inhalers (pMDIs), which spray medication from a pressurized canister. You inhale slowly and steadily, and they work best with a spacer device attached.
Advair Diskus and Breo Ellipta are dry powder inhalers (DPIs). These release medication only when you breathe in quickly and deeply. They don’t use a spacer, and they have built-in dose counters so you always know how many doses remain. The tradeoff is that some people, particularly older adults or those with severe lung disease, may not be able to inhale forcefully enough to get the full dose. DPIs also need to be kept dry, so storing them in a bathroom is a bad idea.
If you’re switching between these types, it’s important to learn the correct technique for your new device. Using a slow, steady breath on a DPI (the way you’d use Symbicort) delivers less medication than it should. Your pharmacist can walk you through proper technique when you pick up a new inhaler.
How Dosing Compares Across Inhalers
These inhalers aren’t milligram-for-milligram interchangeable because they use different steroid compounds. Each has its own dosing scale for low, medium, and high steroid levels. Symbicort comes in two strengths (80/4.5 and 160/4.5 mcg), while Advair HFA comes in three (45/21, 115/21, and 230/21 mcg). Your doctor will match you to the equivalent strength rather than simply swapping one inhaler for another.
For adults and teens, a low daily dose of Symbicort’s steroid component is 320 mcg, while the equivalent low dose for Advair HFA is 180 mcg. These aren’t the same number, but they produce a comparable level of inflammation control. All of these combination inhalers are taken twice daily except Breo Ellipta, which is once daily. Your doctor handles the conversion, but knowing that equivalent doses exist can reassure you that switching doesn’t mean getting less effective treatment.
Finding Your Cheapest Option
The fastest path to savings depends on your insurance situation:
- Commercially insured: Check whether the $35 Symbicort savings card beats your copay for generic Breyna or generic Advair. Sometimes the brand with a coupon is cheaper than the generic on your plan’s formulary.
- Uninsured: Generic fluticasone/salmeterol (generic Advair) tends to have the lowest cash price because it’s been generic the longest. Breyna is another option. Compare prices at multiple pharmacies using a discount card.
- Medicare: Manufacturer savings cards typically don’t apply to government insurance, but AstraZeneca’s AZ&Me program may help. The Inflation Reduction Act’s $2,000 annual out-of-pocket cap on Part D drugs, which took effect in 2025, also limits your total spending on inhalers and other prescriptions.
Ask your doctor or pharmacist to run your specific insurance against a few options. The “cheapest alternative” isn’t universal. It depends on your plan’s formulary, your pharmacy, and which manufacturer programs you qualify for. A five-minute insurance check at the pharmacy counter can reveal that an inhaler you assumed was expensive is actually your most affordable choice.